Quick Answer
RESMED INC reported Net Income Loss of $1.40 billion for the year ending 2025.
- RESMED INC showed an increase of +37.2% in Net Income Loss from 2024 to 2025.
- This data is from RESMED INC's annual report (Form 10-K), filed with the SEC on August 8, 2025.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), RESMED INC's Net Income Loss has grown by 856.5%.
- Historical annual values: Fiscal year 2025: $1.40 billion | Fiscal year 2024: $1.02 billion | Fiscal year 2023: $897.56 million | Fiscal year 2022: $779.44 million | Fiscal year 2021: $474.51 million | Fiscal year 2020: $621.67 million | Fiscal year 2019: $404.59 million | Fiscal year 2018: $315.59 million | Fiscal year 2017: $342.28 million | Fiscal year 2016: $352.41 million | Fiscal year 2015: $352.89 million | Fiscal year 2014: $345.27 million | Fiscal year 2013: $307.13 million | Fiscal year 2012: $254.85 million | Fiscal year 2011: $226.99 million | Fiscal year 2010: $190.09 million | Fiscal year 2009: $146.45 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: